SQUAWK/NEWS
Account
Theme
Account
Menu
Live News FX FLASH L impact

Apotex Q2 adjusted EBITDA excluding VLLP rises 19% to CAD 279.8 million

Apotex Q2 adjusted EBITDA excluding VLLP rises 19% to CAD 279.8 million Apotex’s second-quarter

APOTEX

Related stories